MERZOUKI ABDERRAZZAK (Chief Operating Officer) received a stock award from SUNSHINE BIOPHARMA INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 10/7/2019ACC: 0001128732-19-000032
DirectorOfficer· Chief Operating Officer
Since Aug 2018
+13M
Net shares
Net buyer
$13.0K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
13M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+13M
Price / share
$0.00
Trade value
$13K
% of position
222.2%
9/2/2019
5.85M→18.85M
Total
Net shares
+13M
Net value
$13K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/2/2019 | A · Award | +13M | $0.00 | $13K | 222.2% | 5.85M | 18.85M |
| Total | +13M | $13K | ||||||
Derivative Transactions0
No derivative transactions reported